Thomas D. Mullen

1.9k total citations
20 papers, 1.6k citations indexed

About

Thomas D. Mullen is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Thomas D. Mullen has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Cell Biology. Recurrent topics in Thomas D. Mullen's work include Sphingolipid Metabolism and Signaling (10 papers), Lipid Membrane Structure and Behavior (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Thomas D. Mullen is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Lipid Membrane Structure and Behavior (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Thomas D. Mullen collaborates with scholars based in United States, Canada and China. Thomas D. Mullen's co-authors include Lina M. Obeid, Yusuf A. Hannun, Tarek A. Taha, Jacek Bielawski, Stefka D. Spassieva, Danyelle M. Townsend, Christopher J. Clarke, Russell W. Jenkins, Can E. Senkal and Ping Lü and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Neurology.

In The Last Decade

Thomas D. Mullen

19 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas D. Mullen United States 11 1.4k 305 302 198 149 20 1.6k
W. Christian Wigley United States 22 1.5k 1.1× 445 1.5× 220 0.7× 151 0.8× 65 0.4× 35 2.0k
Krishna R. Juluri United States 13 1.3k 1.0× 430 1.4× 378 1.3× 191 1.0× 93 0.6× 16 2.0k
Daniel Canals United States 27 1.6k 1.2× 438 1.4× 426 1.4× 191 1.0× 85 0.6× 48 2.0k
Benjamin M. Buehrer United States 22 1.1k 0.8× 308 1.0× 400 1.3× 315 1.6× 78 0.5× 32 1.8k
Johnny Stiban Palestinian Territory 16 974 0.7× 194 0.6× 263 0.9× 147 0.7× 117 0.8× 24 1.2k
Nicolas Coant United States 20 785 0.6× 177 0.6× 214 0.7× 154 0.8× 79 0.5× 30 1.2k
Anne‐Françoise Burnol France 24 1.2k 0.9× 236 0.8× 314 1.0× 252 1.3× 111 0.7× 49 1.8k
Robert Jan Veldman Netherlands 20 1.4k 1.0× 387 1.3× 378 1.3× 110 0.6× 84 0.6× 29 1.8k
Rebecca Bachmann United States 5 837 0.6× 220 0.7× 192 0.6× 154 0.8× 116 0.8× 5 1.2k
Vincent Paupe France 16 1.8k 1.3× 268 0.9× 291 1.0× 297 1.5× 75 0.5× 19 2.3k

Countries citing papers authored by Thomas D. Mullen

Since Specialization
Citations

This map shows the geographic impact of Thomas D. Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Mullen more than expected).

Fields of papers citing papers by Thomas D. Mullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Mullen. The network helps show where Thomas D. Mullen may publish in the future.

Co-authorship network of co-authors of Thomas D. Mullen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Mullen. A scholar is included among the top collaborators of Thomas D. Mullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Mullen. Thomas D. Mullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batish, Sat Dev, et al.. (2021). HTT CAG Repeat Length Variation in Huntington Disease (HD) Patients: Experience from a US Reference Laboratory (2376). Neurology. 96(15_supplement). 1 indexed citations
2.
Mullen, Thomas D., Edward Y. Kim, & Smith Apisarnthanarax. (2017). Short-Course Radiation Therapy Versus Long-Course Chemoradiation in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer: New Insights from Randomized Trials. Current Colorectal Cancer Reports. 13(2). 165–174. 6 indexed citations
3.
Mullen, Thomas D., et al.. (2016). Interrater reliability of a near-miss risk index for incident learning systems in radiation oncology. Practical Radiation Oncology. 6(6). 429–435. 5 indexed citations
4.
Mullen, Thomas D., Paul Nghiem, Shailender Bhatia, Upendra Parvathaneni, & J Schwartz. (2016). Merkel Cell Carcinoma Cell Death in Response to Single-Fraction Irradiation: Implications for Immune Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(2). E714–E714. 1 indexed citations
5.
Nyflot, Matthew J., Jing Zeng, Aaron S. Kusano, et al.. (2015). Metrics of success: Measuring impact of a departmental near-miss incident learning system. Practical Radiation Oncology. 5(5). e409–e416. 40 indexed citations
6.
Mullen, Thomas D., et al.. (2015). Assessing the Interrater Reliability of a Near Miss Risk Index for Incident Learning Systems. International Journal of Radiation Oncology*Biology*Physics. 93(3). E501–E501.
7.
Mullen, Thomas D., Yusuf A. Hannun, & Lina M. Obeid. (2012). Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochemical Journal. 441(3). 789–802. 414 indexed citations
8.
Mullen, Thomas D., Anand K. Sharma, & Abhay Varma. (2012). Cervical osteomyelitis after placement of a self‐expanding plastic stent for palliation of dysphagia associated with chemoradiation‐induced esophageal strictures. Head & Neck. 35(6). E197–201. 6 indexed citations
9.
Mullen, Thomas D. & Lina M. Obeid. (2012). Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death. Anti-Cancer Agents in Medicinal Chemistry. 12(4). 340–363. 168 indexed citations
10.
Mullen, Thomas D., Russell W. Jenkins, Christopher J. Clarke, et al.. (2011). Ceramide Synthase-dependent Ceramide Generation and Programmed Cell Death. Journal of Biological Chemistry. 286(18). 15929–15942. 83 indexed citations
11.
Mullen, Thomas D., Stefka D. Spassieva, Russell W. Jenkins, et al.. (2010). Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism. Journal of Lipid Research. 52(1). 68–77. 108 indexed citations
12.
Siskind, Leah J., Thomas D. Mullen, Christopher J. Clarke, et al.. (2010). The BCL-2 Protein BAK Is Required for Long-chain Ceramide Generation during Apoptosis. Journal of Biological Chemistry. 285(16). 11818–11826. 104 indexed citations
13.
White‐Gilbertson, Shai, Thomas D. Mullen, Can E. Senkal, et al.. (2009). Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene. 28(8). 1132–1141. 132 indexed citations
14.
Jin, Junfei, Thomas D. Mullen, Qi Hou, et al.. (2009). AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells. Journal of Lipid Research. 50(12). 2389–2397. 93 indexed citations
15.
Spassieva, Stefka D., Thomas D. Mullen, Danyelle M. Townsend, & Lina M. Obeid. (2009). Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochemical Journal. 424(2). 273–283. 118 indexed citations
16.
Jin, Junfei, Qi Hou, Thomas D. Mullen, et al.. (2008). Ceramide Generated by Sphingomyelin Hydrolysis and the Salvage Pathway Is Involved in Hypoxia/Reoxygenation-induced Bax Redistribution to Mitochondria in NT-2 Cells. Journal of Biological Chemistry. 283(39). 26509–26517. 69 indexed citations
17.
Grenier, N., et al.. (2007). Effectiveness of a nursing support program for patients with recurrent ovarian cancer receiving pegylated liposomal doxorubicin (Caelyx®/Doxil®). Canadian Oncology Nursing Journal. 17(3). 133–136. 3 indexed citations
18.
19.
Taha, Tarek A., Thomas D. Mullen, & Lina M. Obeid. (2006). A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(12). 2027–2036. 262 indexed citations
20.
Grenier, N., et al.. (2005). Nursing support program to decrease or prevent side effects of pegylated liposomal doxorubicin (PLD) in patients with recurrent epithelial ovarian cancer (REOC). Journal of Clinical Oncology. 23(16_suppl). 8198–8198. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Christian Wigley Breakdown of academic impact, for papers by Krishna R. Juluri Breakdown of academic impact, for papers by Daniel Canals Breakdown of academic impact, for papers by Benjamin M. Buehrer Breakdown of academic impact, for papers by Johnny Stiban Breakdown of academic impact, for papers by Nicolas Coant Breakdown of academic impact, for papers by Anne‐Françoise Burnol Breakdown of academic impact, for papers by Robert Jan Veldman Breakdown of academic impact, for papers by Rebecca Bachmann Breakdown of academic impact, for papers by Vincent Paupe
Rankless by CCL
2026